Skip to content

A comparative study of madhukadi vati and panchavalkala kwath prakshalana to manage pelvic inflammatory disease

A comparative clinical study to evaluate the effect of madhukadi vati and panchavalkala kwath prakshalana in the management of paripluta yonivyapada with special reference to pelvic inflammatory disease - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088802
Enrollment
40
Registered
2025-06-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N74- Female pelvic inflammatory disorders in diseases classified elsewhere

Interventions

None listed

Sponsors

State Ayurvedic College and Hospital Tulsidas marg Turiyaganj Lucknow
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Married women between the age group of 21 to 45 years 2 Patient suffering from abnormal vaginal discharge more than 3 consecutive cycles 3 Cardinal symptoms of Paripluta Yonivyapada Lower abdomen pain Low back pain. Dyspareunia Patient willing for trial

Exclusion criteria

Exclusion criteria: 1 Pregnant women 2 Unmarried 3 Patient suffering from any systemic disease like tuberculosis hypertension or diabetes 4 Patient having specific pathology of the genital tract ie benign or malignant tumor 5 Severe or chronic ill health conditions 6 Acute PID and peritonitis tubo ovarian abscess

Design outcomes

Primary

MeasureTime frame
1.To evaluate the efficacy of Madhukadi vati and Panchavalkala Kwath prakshalana in the management of Paripluta yonivyapada. 2.To compare the efficacy of Madhukadi vati and Madhukadi vati with Panchavalkala Kwath prakshalana in the management of Paripluta yonivyapada. Timepoint: after 30 days after 30 days after 30 days of trial

Secondary

MeasureTime frame
1.Conceptual study of Paripluta yonivyapada and its modern correlation. 2.To find out the safe and potent drug for Paripluta yonivyapada 3.Decrease in abnormal vaginal discharges 4.Reduction in pelvic pain 5.To evaluate any adverse effects associated with treatment.Timepoint: after 30 days after 30 days after 30 days of trial

Countries

India

Contacts

Public ContactDrVishakha Masram

State Ayurvedic College and Hospital Tulsidas marg Turiyaganj Lucknow

dr.reshma1411@gmail.com9935010178

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026